EASiUR: Efficient Anterior Shoulder Ultrasound Reduction Multicenter Prospective Randomized Trial

Sponsor
Virginia Commonwealth University (Other)
Overall Status
Terminated
CT.gov ID
NCT04820491
Collaborator
(none)
9
1
2
6.9
1.3

Study Details

Study Description

Brief Summary

The purpose of the study is to determine if using ultrasound to diagnosis and confirm reductions of shoulder dislocations impacts the length of an emergency department visit for this condition.

Condition or Disease Intervention/Treatment Phase
  • Diagnostic Test: X-Ray
  • Diagnostic Test: Ultrasound
N/A

Detailed Description

The purpose of the study is to determine if the length of the emergency department visit can be decreased and if patient exposure to x-rays can be reduced by utilizing an ultrasound to diagnose and confirm reduction in shoulder dislocations.

This study also seeks to determine if patients prefer ultrasound to x-ray when used to treat their shoulder dislocation.

Participants will be randomly assigned to one of two groups: either x-rays or ultrasound for the diagnosis and reduction confirmation of your shoulder dislocation.

Participant's shoulder dislocation will be treated per standard of care.

Participants will be asked to complete a short survey at the end of their visit.

Study Design

Study Type:
Interventional
Actual Enrollment :
9 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Health Services Research
Official Title:
EASiUR Trial: Efficient Anterior Shoulder Ultrasound Reduction Multicenter Prospective Randomized Trial
Actual Study Start Date :
Mar 26, 2021
Actual Primary Completion Date :
Oct 21, 2021
Actual Study Completion Date :
Oct 21, 2021

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: X-Ray

Diagnostic Test: X-Ray
Shoulder x-rays as felt necessary for standard of care of diagnosis of shoulder dislocation and reduction

Active Comparator: Ultrasound

Diagnostic Test: Ultrasound
Initial evaluation with ultrasound; may also evaluate nearby areas for concern of fracture. Order x- rays after ultrasound as seen fit for other injuries of diagnostic uncertainty.

Outcome Measures

Primary Outcome Measures

  1. Length of stay in the Emergency Department (ED) [up to 8 hours or time to admission]

    Length of stay in the ED will be calculated from time of first provider contact to time of discharge from the ED.

Secondary Outcome Measures

  1. Patient satisfaction [at discharge or admission - up to 8 hours]

    Patient satisfaction will be assessed using a 6 item scale. Each item is rated from 1 (extremely dissatisfied) to 5 (extremely satisfied). Scores are summed yielding scores ranging from 6 (most dissatisfied) to 30 (most satisfied).

  2. Time to diagnosis [up to 8 hours or time to admission]

    Time to diagnosis will be calculated from time of first provider contact to time of x-ray or time of ultrasound per treatment condition

  3. Confirmation of reduction [up to 8 hours or time to admission]

    As documented by x-ray or ultrasound per treatment condition

  4. Cost of treatment [up to 8 hours or time to admission]

    Calculated as total billing cost of procedures related to shoulder dislocation ED visit

  5. Total number of xrays [up to 8 hours or time to admission]

    Total number of xrays ordered during time in ED

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  1. Patients who are 18 years of age or older; and

  2. Present to the VCU Emergency Department; and

  3. Have clinical signs of uncomplicated shoulder dislocation; and

  4. Agree to participation in the study; and

  5. Provides a written consent to be included in the study.

Exclusion Criteria:
  1. Patients who have a level 1 or 2 trauma activation, and/or;

  2. Patients who are pregnant, incarcerated, or unable to consent, and/or;

  3. Patients who have a past medical history of shoulder replacement in dislocated shoulder; and/or

  4. Provider Discretion

Contacts and Locations

Locations

Site City State Country Postal Code
1 Virginia Commonwealth University Richmond Virginia United States 23298

Sponsors and Collaborators

  • Virginia Commonwealth University

Investigators

  • Principal Investigator: Jordan Tozer, MD, Virginia Commonwealth University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Virginia Commonwealth University
ClinicalTrials.gov Identifier:
NCT04820491
Other Study ID Numbers:
  • HM20019991
First Posted:
Mar 29, 2021
Last Update Posted:
Apr 14, 2022
Last Verified:
Apr 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
Yes
Product Manufactured in and Exported from the U.S.:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Apr 14, 2022